Pulse Biosciences Inc (PLSE) financials
Pulse Biosciences revenue and earnings by year
Pulse Biosciences's revenue was $350,000 in the fiscal year to December 31, 2025, down 50.0% from the year before. Net income was -$72.8 million, -20794.6% of revenue.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 3 fiscal years
| Fiscal year to | Dec 2025 | Dec 2022 | Dec 2021 |
|---|---|---|---|
| Revenue | 0 | 1 | 1 |
| Revenue growth | -50.0% | -50.6% | — |
| Gross profit | -0 | -11 | -1 |
| Gross margin | -54.0% | -1606.3% | -38.8% |
| Operating income | -77 | -58 | -63 |
| Operating margin | -21982.6% | -8293.9% | -4443.9% |
| Net income | -73 | -59 | -64 |
| Net margin | -20794.6% | -8357.9% | -4489.4% |
| Diluted EPS | -$1.08 | -$1.72 | -$2.29 |
| Free cash flow | -54 | -47 | -55 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open PLSE in Markets.
See also: PLSE returns
No forecast, no recommendation. This page describes Pulse Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.